BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
77 results:

  • 1. Dual-energy computed tomography in a multiparametric regression model for diagnosing lymph node metastases in pancreatic ductal adenocarcinoma.
    Li S; Jiang D; Jiang L; Yan S; Liu L; Ruan G; Zhou X; Zhuo S
    Cancer Imaging; 2024 Mar; 24(1):38. PubMed ID: 38504330
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer.
    Zang L; Zhang B; Zhou Y; Zhang F; Tian X; Tian Z; Chen D; Miao Q
    Aging (Albany NY); 2023 Dec; 15(23):14109-14140. PubMed ID: 38095640
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study.
    Zhang G; Nie F; Zhao W; Han P; Wen J; Cheng X; Wu W; Liu Q; Sun Y; Wang Y; Liu Y; Ren F
    World J Surg Oncol; 2023 Nov; 21(1):357. PubMed ID: 37986077
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic Performance of Bile Duct Brush Cytology with Risk of Malignancy of Standardized Categories in the Wake of World Health Organization Reporting System for pancreaticobiliary Cytopathology: An Updated Systematic Review and Meta-Analysis.
    Rath A; Pradeep I; Nigam JS
    Acta Cytol; 2023; 67(6):639-649. PubMed ID: 37879315
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. New cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma.
    Liu S; Hu Q; Xie Z; Chen S; Li Y; Quan N; Huang K; Li R; Fang L
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15589-15608. PubMed ID: 37653101
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cd74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in pancreatic cancer.
    Hong WC; Lee DE; Kang HW; Kim MJ; Kim M; Kim JH; Fang S; Kim HJ; Park JS
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629174
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Regorafenib compared to nivolumab after sorafenib failure in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
    Yang S; Zhou Y; Zeng L
    Adv Clin Exp Med; 2023 Aug; 32(8):839-845. PubMed ID: 37140014
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Alterations of commensal microbiota are associated with pancreatic cancer.
    Chen T; Li X; Li G; Liu Y; Huang X; Ma W; Qian C; Guo J; Wang S; Qin Q; Liu S
    Int J Biol Markers; 2023 Jun; 38(2):89-98. PubMed ID: 37017014
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Sha S; Wang Y; Liu M; Liu G; Fan N; Li Z; Dong W
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954297
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BUB1 Is Identified as a Potential Therapeutic Target for pancreatic cancer Treatment.
    Li M; Duan X; Xiao Y; Yuan M; Zhao Z; Cui X; Wu D; Shi J
    Front Public Health; 2022; 10():900853. PubMed ID: 35769782
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
    Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
    Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Trends in Preoperative Chemotherapy Utilization for Proximal pancreatic cancer: Are We Making Progress?
    Mellado S; Vega EA; Abudalou M; Kutlu OC; Salehi O; Li M; Kozyreva O; Freeman R; Conrad C
    J Gastrointest Surg; 2022 Aug; 26(8):1-7. PubMed ID: 35508681
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. cd74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization.
    Werr L; Plenker D; Dammert MA; Lorenz C; Brägelmann J; Tumbrink HL; Klein S; Schmitt A; Büttner R; Persigehl T; Shokat KM; Wunderlich FT; Schram AM; Peifer M; Sos ML; Reinhardt HC; Thomas RK
    Mol Cancer Ther; 2022 May; 21(5):821-830. PubMed ID: 35247925
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
    Schram AM; Odintsov I; Espinosa-Cotton M; Khodos I; Sisso WJ; Mattar MS; Lui AJW; Vojnic M; Shameem SH; Chauhan T; Torrisi J; Ford J; O'Connor MN; Geuijen CAW; Schackmann RCJ; Lammerts van Bueren JJ; Wasserman E; de Stanchina E; O'Reilly EM; Ladanyi M; Drilon A; Somwar R
    Cancer Discov; 2022 May; 12(5):1233-1247. PubMed ID: 35135829
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer.
    Liu Z; Guo C; Dang Q; Wang L; Liu L; Weng S; Xu H; Lu T; Sun Z; Han X
    EBioMedicine; 2022 Jan; 75():103750. PubMed ID: 34922323
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Application of a novel surgical difficulty grading system during laparoscopic cholecystectomy.
    Asai K; Iwashita Y; Ohyama T; Endo I; Hibi T; Umezawa A; Suzuki K; Watanabe M; Kurata M; Mori Y; Higashida M; Kumamoto Y; Shindoh J; Yoshida M; Honda G; Misawa T; Abe Y; Nagakawa Y; Toyota N; Yamada S; Norimizu S; Matsumura N; Sata N; Sunagawa H; Ito M; Takeda Y; Nakamura Y; Rikiyama T; Higuchi R; Gocho T; Homma Y; Hirashita T; Kanemoto H; Nozawa M; Watanabe Y; Kohga A; Yazawa T; Tajima H; Nakahira S; Asaoka T; Yoshioka R; Fukuzawa J; Fujioka S; Hata T; Haruta H; Asano Y; Nomura R; Matsumoto J; Kameyama N; Miyoshi A; Urakami H; Seyama Y; Morikawa T; Kawano Y; Ikoma H; Kin DHK; Takada T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):758-767. PubMed ID: 34748289
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis.
    Hu L; Zhu M; Shen Y; Zhong Z; Wu B
    World J Surg Oncol; 2021 Oct; 19(1):300. PubMed ID: 34654443
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
    Ullgren H; Fransson P; Olofsson A; Segersvärd R; Sharp L
    PLoS One; 2021; 16(7):e0254673. PubMed ID: 34270589
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.